发明名称 Thiazolidine and oxazolidine derivatives their preparation and their medical use
摘要 Compounds of formula (I): <CHEM> [in which: R<1> and R<2> are each hydrogen or alkyl, or together a group of formula -(CH2)k- in which k is an integer; R<3> is hydrogen, alkyl, alkoxy, halogen or hydroxy; A and B are each hydrogen, alkyl, aralkyl, aliphatic carboxylic acyl, aryl-substituted aliphatic carboxylic acyl, aromatic carboxylic acyl or carbamoyl, or A and B together represent >C=O, >C=S, -C(=O)-C(=O)-, -CH2C(=O)-, -CH2CH2-, -SO2- or -CH2SO2-; X is a group of formula: W-(CH2)m-X<1>- in which W is aryl or heterocyclic, X<1> is a single bond, oxygen, sulphur or >NR<4> in which R<4> is hydrogen, alkyl, aralkyl or aryl, and m is 0 or an integer; Y is a group of formula: -(CH2)n-Y<1>-, in which Y<1> is a single bond, oxygen or sulphur, and n is an integer; Z is a group of formula (i), (ii), (iii), (iv), (v) or (vi): <CHEM> <CHEM> <CHEM> in which R<5> is hydrogen, carboxyalkyl, alkanoyloxyalkyl, cycloalkyl-substituted alkanoyloxyalkyl, cycloalkylcarbonyloxyalkyl, alkoxycarbonyloxyalkyl, cycloalkyl-substituted alkoxycarbonyloxyalkyl or cycloalkyloxycarbonyloxyalkyl group]; and salts, esters and solvates thereof and pro-drugs therefor are useful for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, glucose tolerance insufficiency, insulin resistance and diabetic complications.
申请公布号 ZA9502383(B) 申请公布日期 1995.12.14
申请号 ZA19950002383 申请日期 1995.03.23
申请人 SANKYO COMPANY LIMITED. 发明人 TAKASHI FUJITA;HIROAKI YANAGISAWA;HIROYOSHI HORIKOSHI;KUNIO WADA;TAKAO YOSHIOKA;TOSHIHIKO FUJIWARA;MINORU OGUCHI;KOICHI FUJIMOTO
分类号 A61K31/17;A61K31/41;C07D263/44;C07D271/06;C07D277/34;C07D291/04;C07D413/10;C07D417/10;C07D417/12;C07D417/14;C07D419/10 主分类号 A61K31/17
代理机构 代理人
主权项
地址
您可能感兴趣的专利